A Dutch investigative report has revealed that the 2006 study upon which the entire medical experiment of child sex changes is based was funded by a maker of puberty blockers.
The Dutch protocol was the result of a deeply flawed 2006 study which it has now been revealed was funded by Ferring pharmaceuticals, the company that markets the drug Triptorelin as a puberty blocker.
Libby Emmons: "If a child goes on puberty blockers and then goes directly on to cross-sex hormones & does not go through natural puberty, they will never orgasm."